
As geopolitical tensions and energy market volatility weigh on European indices, investors are increasingly focused on the potential for central bank tightening in response to inflation concerns. Amidst this uncertain environment, identifying stocks that may be trading below their intrinsic value can offer opportunities for those looking to navigate the current market landscape.
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Vossloh (XTRA:VOS) | €63.35 | €123.92 | 48.9% |
| TGS (OB:TGS) | NOK130.80 | NOK256.19 | 48.9% |
| Murapol (WSE:MUR) | PLN37.90 | PLN75.27 | 49.7% |
| Micro Systemation (OM:MSAB B) | SEK82.20 | SEK159.41 | 48.4% |
| Laboratorios Farmaceuticos Rovi (BME:ROVI) | €56.00 | €109.13 | 48.7% |
| Koskisen Oyj (HLSE:KOSKI) | €8.78 | €17.42 | 49.6% |
| Jerónimo Martins SGPS (ENXTLS:JMT) | €16.38 | €31.87 | 48.6% |
| F-Secure Oyj (HLSE:FSECURE) | €2.035 | €3.93 | 48.2% |
| Fasadgruppen Group (OM:FG) | SEK18.98 | SEK36.46 | 47.9% |
| Casta Diva Group (BIT:CDG) | €3.15 | €6.11 | 48.4% |
Let's take a closer look at a couple of our picks from the screened companies.
Overview: Digi Communications N.V. offers telecommunication services in Romania, Spain, Portugal, and Belgium, as well as mobile telephony services in Italy, with a market cap of RON16.95 billion.
Operations: The company generates revenue primarily from its wireless communications services, amounting to €2.33 billion.
Estimated Discount To Fair Value: 32.6%
Digi Communications is trading at RON61, significantly below its estimated future cash flow value of RON90.46, indicating it may be undervalued. Despite a recent net loss of EUR 16.22 million in Q1 2026, the company is expected to achieve above-market annual profit growth over the next three years and revenue growth at 7.5% per year. However, interest payments are not well covered by earnings, and return on equity is forecasted to remain low at 12.6%.
Overview: RVRC Holding AB (publ) operates in the e-commerce outdoor clothing sector, serving markets in Germany, Sweden, and internationally, with a market cap of SEK6.51 billion.
Operations: The company's revenue primarily comes from its retail apparel segment, which generated SEK2.10 billion.
Estimated Discount To Fair Value: 35.8%
RVRC Holding is trading at SEK61.5, well below its estimated future cash flow value of SEK95.86, suggesting it could be undervalued. Recent earnings reports show net income growth from SEK63 million to SEK83 million year-over-year for the third quarter. The company's earnings are projected to grow 18% annually, outpacing the Swedish market's 8.6%, with analysts predicting a potential stock price increase of 28.9%. An acquisition aligns with RVRC's strategic goals, potentially enhancing long-term value.
Overview: Stille AB develops, manufactures, and distributes medtech products across various international markets, with a market cap of SEK2.43 billion.
Operations: The company's revenue primarily comes from two segments: Surgical Instruments, generating SEK469.45 million, and Surgical Tables, contributing SEK147.96 million.
Estimated Discount To Fair Value: 41.9%
Stille is trading at SEK270.5, significantly below its estimated future cash flow value of SEK465.5, indicating potential undervaluation. Earnings are expected to grow 22.4% annually, exceeding the Swedish market's 8.6%. First-quarter results showed sales growth from SEK129.29 million to SEK179.07 million and net income rising from SEK14.62 million to SEK20.92 million year-over-year, despite a forecasted low return on equity of 12.7% in three years and slower revenue growth compared to high-growth benchmarks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com